Daejeon, South Korea

Huu Tung Nguyen

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Rnl Bio Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huu Tung Nguyen. Retrieved from https://idiyas.com/inventor/huu-tung-nguyen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huu Tung Nguyen: Innovator in Viral Inhibition

Introduction

Huu Tung Nguyen is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds with viral inhibitory activity.

Latest Patents

Nguyen holds a patent for diaryl hepatonoid-based compounds, which are described as having viral inhibitory activity. The patent outlines a compound of formula (1) along with its pharmaceutically acceptable salts, hydrates, solvates, or prodrugs. This invention is particularly valuable as it offers therapeutic agents that can effectively inhibit viral activity, making it useful in treating virus-related diseases.

Career Highlights

Throughout his career, Huu Tung Nguyen has demonstrated a commitment to advancing medical science through innovative research. His work at Rnl Bio Co., Ltd. has positioned him as a key player in the development of new therapeutic agents.

Collaborations

Nguyen has collaborated with notable colleagues, including Jeong Chan Ra and Young Ho Kim, to further enhance the research and development of viral inhibitory compounds.

Conclusion

Huu Tung Nguyen's contributions to the field of viral inhibition through his innovative compounds highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic solutions against viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…